China News Service, Hangzhou, April 28 (Reporter Guo Qiyu) How are scientific research achievements transformed?
How to obtain more scientific and technological support for enterprise development?
At the "Scientists + Entrepreneurs" Roundtable Meeting of "Scientists + Entrepreneurs" held by the Zhejiang European and American Students Association and the Zhejiang Chamber of Commerce recently, scientists and entrepreneurs from the field of life sciences conspired to cooperate in industry-university-research innovation, and connect from strong technology to strong enterprises Then to the key link of industrial strength.
Under the global pandemic of the new crown epidemic, life sciences have received particular attention.
At present, Zhejiang is working together to build three high-tech innovation highlands including life and health highlands, integrating various technological elements into fists, and supporting efficient collaborative research while strengthening innovation-driven development.
"At present, the development of life sciences in Zhejiang is good. On the one hand, it relies on several affiliated hospitals of Zhejiang University School of Medicine and has abundant clinical resources; on the other hand, the biomedical industry has a good foundation." Academician of the Chinese Academy of Sciences, Shanghai Jiaotong University Dong Chen, a professor at the School of Medicine, said.
He believes that the development of the field of life sciences focuses on bringing together talents, that is, attracting and cultivating talents globally. At the same time, this is also a discipline that requires an international perspective and adheres to an international path.
In response to Zhejiang's development path, Dong Chen suggested that Zhejiang should be good at giving full play to the power of the people, integrating the institutional advantages of the government, the talent innovation advantages of universities and research institutes, and the efficiency advantages of "market allocation of resources".
As a research expert in the field of life sciences, Feng Xinhua, dean of the Institute of Life Sciences of Zhejiang University and chair professor of Qiushi, admitted that while doing basic research, he also hopes that his research results can be transformed to promote the development of the biomedical industry. development, so that the value of scientific research serving the cause of human life and health is more practically reflected.
"Building a highland of life and health requires multi-party cooperation, especially to increase support for basic research in scientific research institutions in colleges and universities, because basic research is the source of the entire scientific system." Feng Xinhua suggested that financial and policy support for systems with innovative capabilities and distinctive directions. New R&D institutions, such as encouraging new R&D institutions to go beyond product R&D functions, deploy platforms, systems, and ecosystems.
At the same time, we can try to "diversify" the investment entities of new R&D institutions and "market-oriented" the operation mechanism.
"Gathering intelligence to tackle key problems is all possible." When more social forces consciously participate in innovation and research and development, it means that an innovation matrix is being formed.
Ding Lieming, Vice President of Zhejiang European and American Students Association, Vice President of Zhejiang Chamber of Commerce and Chairman of Betta Pharmaceuticals Co., Ltd., has been committed to the research and development of innovative drugs since returning to China. The targeted anticancer drug Conmana developed by his team has won the The first prize of National Science and Technology Progress Award.
"In the past year, more than 20 domestic innovative drugs have been approved for marketing by the State Drug Administration, and the number is gradually approaching that of the United States. Many innovative drugs have approached or reached the international advanced level." Ding Lieming said that from the perspective of research and development, China's new drugs R&D has gone through the stages of "tracking imitation" and "imitation innovation", and is entering a new stage of original innovation.
At the same time, he pointed out that since China's innovative drug research and development started late and the starting point is not high enough, it is necessary to further optimize the scientific and technological innovation ecology, promote collaborative innovation, and encourage multiple parties to jointly promote the independent research and development of new drugs.
At the meeting, Zhou Guohui, vice chairman of the Zhejiang Provincial Committee of the Chinese People's Political Consultative Conference, said that scientists play a prominent role in major innovation breakthroughs, innovation policy enhancement, innovation industry development, and the introduction and cultivation of scientific and technological talents. The development resilience and development vitality have made great contributions. Both sides are important forces that Zhejiang needs to rely on.
"Currently, economic and social development and people's livelihood are more in need of scientific and technological solutions than ever in the past, and it is even more necessary to strengthen innovation, the primary driving force for development." Zhou Guohui said that only scientists and entrepreneurs can pragmatically carry out industry-university-research cooperation. Only by truly realizing the application of basic research and the transformation of new technology achievements can a strong productivity be formed.
(Finish)